EFFICACY OF STENT-SUPPORTED SUBINTIMAL ANGIOPLASTY IN ILIAC ARTERY OCCLUSIVE DISEASE.  by Shin, Sanghoon et al.
A160.E1504
JACC Maarch 9, 2010
Volume 55, issue 10A
 VASCULAR DISEASE
EFFICACY OF STENT-SUPPORTED SUBINTIMAL ANGIOPLASTY IN ILIAC ARTERY OCCLUSIVE DISEASE.
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 3:30 p.m.-4:30 p.m.
Session Title: Peripheral Arterial/Carotid Disease/Aortic Disease
Abstract Category: Peripheral Arterial/Carotid Disease/Aortic Disease
Presentation Number: 1109-340
Authors: Sanghoon Shin, Young-Guk Ko, Jung-Sun Kim, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang, Won-Heum Shim, Seung-Yun Cho, Division of 
Cardiology, Severance Cardiovascular Hospital, Yonsei University, Seoul, South Korea
Background: Subintimal angioplasty(SA) is increasingly accepted as a revascularization technique for chronic arterial occlusive disease. However, 
its efficacy in iliac artery occlusions has not been established. Thus, we investigated the procedural and clinical outcomes of subintimal angioplasty 
in iliac artery occlusive lesions and compared them with those of intraluminal angioplasty(IA) in stenotic, but non-occlusive iliac artery lesions.
Methods: We retrospectively analyzed data on 139 consecutive patients (159 men, mean age 64.36±9.0 years) with iliac artery lesions (182 
limbs) who underwent stent-supported angioplasty from October 2004 through July 2008. Baseline characteristics and procedural and clinical 
outcomes of patients treated with SA (n=52, 59 limbs) were compared with those of patients treated with IA (n=104, 126 limbs).
Results: Baseline characteristics of both groups were similar, but Lesion length was significantly longer in SA group (81.63±40.39mm) than IA 
group (45.37±23.00mm) (p-value<0.001). The number of stents used for each lesion was 1.36±0.55 in SA versus 1.08±0273 in IA (p<0.001). 
Concurrent angioplasty for other lesions in the same limbs was performed in 27/58 (46.6%) in SA and 49/124 (39.5%) in IA (p=0.370). Immediate 
procedural success was achieved in all patients of both groups. SA group had no case of complications requiring surgery, but there was one case of 
distal embolization requiring amputation in IA group. Primary patency at 24 months was 96.2% in SA and 97.4% in IA (p=0.378).
Conclusion: Stent-supported SA in occlusive iliac lesions was safe and showed a high long-term patency rate comparable to that of IA performed 
in non-occlusive iliac lesions despite longer lesion length. Our data suggest SA might replace surgery in the majority of iliac artery occlusions for 
which surgical treatment has been the standard therapy.
